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============

Additional information about the cardiovascular status of critically ill patients can be obtained by measuring cardiac output (CO). Pulmonary artery thermodilution CO monitoring has remained the reference technique for three decades \[[@CR1]\] but is invasive and associated with specific complications \[[@CR2]--[@CR4]\]. Thoracic bioimpedance cardiography, a noninvasive CO monitoring technique, exhibits many qualities of the ideal CO monitor: it is operator independent, continuous, and cost-effective \[[@CR5]\]. Since the late 1960s a number of bioimpedance devices have been developed with cylinder- or cone-based models of a homogeneously with blood filled human thorax. Method comparison studies have demonstrated conflicting results with respect to validity and reliability \[[@CR6]\], varying from satisfactory correlations \[[@CR7]--[@CR9]\] to poor correlations \[[@CR10], [@CR11]\]. Inaccuracies can result from irregular cardiac rhythms, abnormal ventilatory patterns, motion artifacts, valvular heart diseases, electrocautery, changes in hematocrit, excessive changes in body temperature, and an obese body habitus \[[@CR5]\]. Thereby, it remains unclear whether the methodology (i.e. detection of impedance signals from the thorax using a small number of electrodes) per se or limitations of the underlying algorithms are responsible for these conflicting results. We hypothesized that bioimpedance SV measured with any of three well-established bioimpedance algorithms is valid and reliable. We compared bioimpedance stroke volume index (SVI) with transpulmonary thermodilution stroke volume index (SVI~TD~) as a reference of proven accuracy \[[@CR12]\].

Materials and methods {#Sec3}
=====================

After approval by the institutional review board and written informed consent, patients scheduled for elective coronary artery bypass graft (CABG) surgery with cardiopulmonary bypass were included. Exclusion criteria were: ejection fraction less than 40%, femoral arterialdisease, and valvular heart disease. A total intravenous anesthesia technique was used during the operation. Normocapnia was maintained during mechanical ventilation (inspired fraction of oxygen 0.4, positive end-expiratory pressure 5 cmH~2~O).

A4-Fthermodilutioncatheter(PulsiocathPV2014 L16) was introduced into the femoral artery and connected to a commercially available CO device (PiCCO, Pulsion,Munich, Germany). Transpulmonary thermodilution cardiac output (TPCO) was measured by quadruple injections of 15 ml ice-cold saline into the right atrium and used for transpulmonary thermodilution stroke volume calculation.

After rubbing and cleaning the skin with alcohol to achieve a skin-to-electrode impedance as low as possible, two "current injecting" electrodes were placed on the forehead and the left hip, and two voltage sensing electrodes were placed on the lateral side of the neck just above the left clavicle and in the left midaxillary line at the level of the sternal xiphoid. An alternating current of 0.3 mA (64 kHz) was applied. A thoracic bioimpedance cardiograph (HL-4, Hemologic, Amersfoort, The Netherlands) was used for recording raw bioimpedance signals in the perioperative period. The first derivative of the thoracic impedance (dZ/dt) and the electrocardiographic signal were displayed on the screen. Raw data were analyzed off-line over a 20-s period (LabView, E-solutions, Arnhem, The Netherlands) and used for bioimpedance SV calculation using three distinct reconstruction algorithms: Kubicek et al. \[[@CR13]\], Sramek--Bernstein \[[@CR14]\], and Wang et al. \[[@CR15]\].

Data collected after induction before skin incision (*t*~1~), after weaning from cardiopulmonary bypass (*t*~2~), after sternal closure (*t*~3~), after admission at the intensive care (*t*~4~), after reaching normothermia (36.5 °C) (*t*~5~), after extubation (*t*~6~), and before discharge to the ward (*t*~7~) were: heart rate, mean arterial pressure, central venous pressure, bioimpedance raw data and TPCO measurements. SVI was calculated by dividing stroke volume by body surface area.

Sample size calculation was performed to limit the width of a 95% confidence interval for the mean error; based on a mean CO of 5.0 l/min, a correlation coefficient of 0.65, a mean error of 30% \[[@CR16]\], and a confidence interval of 95%, a sample size of 20 patients was calculated.

Statistical analysis was performed using PRISM 4.0 (GraphPad, San Diego, Calif., USA) and SPSS 12.0.2 (SPSS, Chicago, Ill., USA). If the analysis of variance revealed a significant interaction, post-hoc analysis was performed using Student\'s *t* test with Bonferroni\'s correction. Validity and reproducibility between bioimpedance SVI and SVI~TD~ were tested according to Bland and Altman \[[@CR17]\]: bias, precision (= SD of bias), limits of agreement (LOA), and mean error \[[@CR15]\] for absolute SVI values and for relative changes in SVI (ΔSVI). Mean error was calculated as 2 × precision divided by the mean SVI~TD~. Pooled data and data per time moment were analyzed. A *p* value less than 0.05 was considered to indicate statistical significance.

Results {#Sec4}
=======

The population studied included 15 men and 5 women (age 64 ± 10 years, weight 79 ± 12 kg, height 171 ± 8 cm; body surface area 1.64--2.20 m^2^). Of 140 SVI series obtained 93 with each technique were available for statistical analysis. Forty seven series of SVI data could not be used for further analysis because of failure to obtain SVI due to insufficient raw bioimpedance signals. Time course of SVI and Bland--Altman analysis for each method are shown in Fig. [1](#Fig1){ref-type="fig"}. Bias, precision, LOA, and mean error between SVI~TD~ and SVI~K~ were 1.0 ± 10.8 ml/m^2^, −20.2 to +22.1 ml/m^2^, and 63%, respectively, while the results for SVI~TD~ and SVI~SB~ were 9.8 ± 11.4 ml/m^2^, --12.5 to +32.2 ml/m^2^, and 67% and for SVI~TD~ and SVI~W~ −15.7 ± 8.2 ml/m^2^, −31.6 to +0.3 ml/m^2^, and 48,% respectively. Analysis of bioimpedance data for each algorithm at each time point are given in Table [1](#Tab1){ref-type="table"}. Fig. 1Time course of stroke volume index (*SVI*) and Bland--Altman analysis obtained by each method. *SVI*~*TD*~, Transpulmonary thermodilution stroke volume index; *SVI*~*K*~, stroke volume index according to Kubicek et al. \[[@CR13]\]; *SVI*~*SB*~, stroke volume index according to Sramek--Bernstein \[[@CR14]\]; *SVI*~*W*~, stroke volume index according to Wang et al. \[[@CR15]\]. \**p* \< 0.05 vs. *t*~1~Table 1Bias, precision, limits of agreement (*LOA*), and mean error of stroke volume index calculated with three bioimpedance algorithms vs. transpulmonary thermodilution stroke volume index (*SVI*~*TD*~) for each time moment (*t*~1~, after induction before skin incision; *t*~2~, after weaning from CPB; *t*~3~, after sternal closure; *t*~4~, after admission at the intensive care unit; *t*~5~, after reaching normothermia at 36.5 °C; *t*~6~, after extubation; *t*~7~, before discharge to the ward; *SVI*~*K*~, stroke volume index according to Kubicek et al. \[[@CR13]\]; *SVI*~*SB*~, stroke volume index according to Sramek--Bernstein \[[@CR14]\]; *SVI*~*W*~, stroke volume index according to Wang et al. \[[@CR15]\])SVI~K~SVI~SB~SVI~W~timeBias (ml/m--2)Precision (ml/m--2)LOA (ml/m--2)Mean error (%)Bias (ml/m--2)Precision (ml/m--2)LOA (ml/m--2)Mean error (%)Bias (ml/m--2)Precision (ml/m--2)LOA (ml/m--2)Mean error (%)*t*~1~6.413.9--20.8, +33.67715.512.3--8.6, +39.668--14.79.8--33.9, +4.554*t*~2~0.68.8--16.6, +17.85111.89.3--6.4, +30.054--13.04.8--22.5,-- 3.528*t*~3~--3.07.8--18.3, +12.4516.213.9--21.0, +33.490--14.28.1--30.2, +1.753*t*~4~1.08.4--15.5, +17.6569.95.4--0.7, +20.436--13.85.8--25.1,-- 2.538*t*~5~0.410.0--19.2, +20.05810.110.7--10.9, +31.162--16.38.6--33.1, +0.650*t*~6~1.513.3--24.5, +27.5737.212.1--16.4, +30.966--17.89.5--36.4, +0.852*t*~7~--0.610.7--21.5, +20.4608.313.0--17.2, +33.872--18.08.1--34.0, --2.145

Discussion {#Sec5}
==========

This study compared three bioimpedance algorithms assessing bioimpedance SVI to SVI~TD~ during the perioperative period in CABG patients. However, significant deviations were found, and accurate clinical decision making was not possible based on absolute values or changes in bioimpedance SVI. No single algorithm was superior to another. Interestingly, application of the Wang algorithm produced consistent underestimation, whereas the two other algorithms overestimated SVI. Our study differed from previous studies in several important aspects. Raw voltage data were measured and used for off-line calculation of bioimpedance SVI on the basis of different bioimpedance algorithms commonly used in commercially available devices. Therefore data were obtained without using different bioimpedance devices and calculation was independent from built-in proprietary software algorithms. Measurements were performed not only in the operating room but also in the intensive care in ventilated as well as in spontaneously breathing patients.

The difference between bioimpedance SVI and SVI~TD~ for any of the three algorithms may be explained by the fact that the relationship between the signal on the voltage sensing electrodes and the resulting SVI is based on assumptions in relation to multiple effects. Whereas SV is equal to the change in the left ventricular volume during the systole, the voltage signal measured with bioimpedance is a result of volume changes in different intrathoracic compartments during the cardiac cycle, such as the intracardiac cavities, aorta, superior and inferior vena cava, and pulmonary circulation on the "injected" current \[[@CR18]\]. Vascular diseases (atherosclerosis) can affect the relative contribution of the aorta to the bioimpedance signal because the volume change in the aorta during the cardiac cycle depends on aortic compliance. Moreover, a considerable anatomical variability exists between patients and within the cardiac cycle. The orientation of the central heart axis in relation to the thorax cavity varies considerably between patients but also during the cardiac cycle. Both influence the main current density field and hence the relative contribution of SV to the bioimpedance signal. It is questionable whether it is even possible to measure SVI reliably using thoracic bioimpedance with only one single voltage input stream given the fact that each of three distinctly different algorithms failed to produce satisfactory agreement with SVI~TD~. Therefore an increase in the number of data input streams (i.e. electrodes) may improve the validity and reliability of the technique. Consequently suggestions have been made to optimize the measurement technique and the basic bioimpedance SV equation \[[@CR19]\].

Recently Spiess et al. \[[@CR8]\] and Sageman et al. \[[@CR9]\] studied a second-generation thoracic bioimpedance cardiograph (BioZ System 1.52, Cardiodynamics International, San Diego, Calif., USA) in CABG patients and found a clinically acceptable correlation between pulmonary artery thermodilution and bioimpedance. However, mean error in the study by Spiess et al. was 26% after induction of anesthesia and exceeded the clinically acceptable 30% during the other measurements \[[@CR8]\]. In contrast, our study showed a mean error exceeding 30% with the exception of *t*~2~ using the Wang algorithm.

In conclusion, common cylinder- and cone-based models for bioimpedance SVI calculation are not reliable compared to SVI~TD~ measurements in CABG patients. These models are oversimplifications of the complex electrical events occurring inside the thorax during the cardiac cycle. The problem of retrieving SV from voltage data may be considered as a special case of the general inverse conductivity theory \[[@CR20]\]. There is need for a more robust mathematical approach (see Electronic Supplementary Material), including an increase in the number of voltage measurement input streams, an accurate description of the physics of current density distributions and taking into account the full spectrum of all relevant patient anatomical variabilities.
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